- Trials with a EudraCT protocol (476)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
476 result(s) found for: PCP.
Displaying page 1 of 24.
EudraCT Number: 2020-002306-12 | Sponsor Protocol Number: GB004-2101 | Start Date*: 2021-01-12 | |||||||||||
Sponsor Name:GB004, Inc. | |||||||||||||
Full Title: A Phase 2, randomized, double-blind, placebo-controlled, multi-center study to evaluate GB004 in adult subjects with mild-to-moderate active ulcerative colitis | |||||||||||||
Medical condition: Mild-to-moderate active ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Prematurely Ended) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022413-26 | Sponsor Protocol Number: IDEAL-Study | Start Date*: 2011-07-29 | |||||||||||
Sponsor Name:University Medical Center Hamburg-Eppendorf | |||||||||||||
Full Title: Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (IDEAL-Study) | |||||||||||||
Medical condition: Patients in late stage of HIV-infection, treatment naive or without ART for the last 6 month with an acute AIDS-defining illness, namely PCP or TE. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005169-39 | Sponsor Protocol Number: D9914C00002 | Start Date*: 2005-08-11 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A single-blind single arm study to validate the Reflux Disease Questionnaire (RDQ) for the diagnosis of reflux disease in primary care in patients treated with esomeprazole 40 mg o.d. | ||
Medical condition: Symptoms from the upper gastrointestinal tract | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) GB (Completed) DE (Completed) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-017325-19 | Sponsor Protocol Number: FI-08-03 | Start Date*: 2010-02-11 | ||||||||||||||||||||||||||
Sponsor Name:Helsingin reumakeskus | ||||||||||||||||||||||||||||
Full Title: “The effect of Six months Adalimumab Treatment on Sick Leaves and retirement in Patients with rheumatoid Arthritis who are at risk of losing their ability to work” | ||||||||||||||||||||||||||||
Medical condition: Rheumatoid arthritis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023469-22 | Sponsor Protocol Number: P10.YYY/ APCP-107 | Start Date*: 2011-03-09 | ||||||||||||||||
Sponsor Name:LUMC | ||||||||||||||||||
Full Title: A phase II study of ARA 290 as therapeutic strategy in rheumatoid arthritis | ||||||||||||||||||
Medical condition: Rheumatoid arthritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020917-97 | Sponsor Protocol Number: ARC209 | Start Date*: 2010-06-23 | ||||||||||||||||
Sponsor Name:ASSOCIAZIONE ITALIANA PNEUMOLOGI OSPEDALIERI | ||||||||||||||||||
Full Title: SPHERIC-1 (Sildenafil in the Chronic Obstructive Pulmonary Disease associated to Chronic Pulmonary Hypertension. Sixteen weeks long, multicentre, randomized, double blind study, in comparison with ... | ||||||||||||||||||
Medical condition: Moderate to severe pulmonary hypertension associated to moderate to mild COPD. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-001825-69 | Sponsor Protocol Number: Estensione RA 1 | Start Date*: 2005-11-04 | |||||||||||
Sponsor Name:THERAKOS | |||||||||||||
Full Title: A Multi Center, Open label, Extension study of RA 1 using Extracoproreal photoimmune therapy with Uvadex | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006562-42 | Sponsor Protocol Number: RD-5103-007-06 | Start Date*: 2008-02-21 | |||||||||||
Sponsor Name:Derby Hospitals NHS Foundation Trust | |||||||||||||
Full Title: An Observational and Exploratory Study to determine the effect of anti TNF Biologic Treatment in Rheumatoid Cachexia | |||||||||||||
Medical condition: Cachexia in patients with Rheumatoid arthritis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005391-40 | Sponsor Protocol Number: PRPINAR2006 | Start Date*: 2006-09-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SENESE | |||||||||||||
Full Title: Study on the effect of intra-articular infiltrations of aulogous platelet gel as inhibitor of erosion in rheumatoid arthritis patients | |||||||||||||
Medical condition: Patients with Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000491-16 | Sponsor Protocol Number: CACZ885A2201E1 | Start Date*: 2007-04-30 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A. | |||||||||||||
Full Title: Estudio de extensión abierto de 76 semanas de duración para evaluar la eficacia, seguridad y tolerabilidad de ACZ885 (anticuerpo monoclonal anti-interleuquina-1β) en pacientes con artritis reumatoi... | |||||||||||||
Medical condition: Artritis Reumatoide | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Prematurely Ended) AT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015835-34 | Sponsor Protocol Number: OM-2009-001 | Start Date*: 2010-04-09 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA ORDINE MAURIZIANO | |||||||||||||
Full Title: VITAMIN D EFFECT ON T LYMPHOCYTES AND OSTEOCLASTOGENESIS IN RHEUMAOID ARTHRITIS | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005386-19 | Sponsor Protocol Number: Anti TNF resistant RA / RTX / mini | Start Date*: 2006-12-19 | |||||||||||
Sponsor Name:Cliniques Universitaires Saint-Luc | |||||||||||||
Full Title: Cytokines and inflammatory proteins gene expression study in synovial biopsies from rheumatoid arthritis patients refractory to anti-TNF therapy treated with Rituximab | |||||||||||||
Medical condition: Rheumatoid arthritis refractory to TNF blockers patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000587-17 | Sponsor Protocol Number: MA21573 | Start Date*: 2008-06-18 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: Multi-National Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients with Active Rheumatoid Arthritis on Background Non-biologic DMARDs who have an Inadequat... | |||||||||||||
Medical condition: Rheumatoid arthritis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) AT (Completed) SE (Completed) ES (Completed) FI (Completed) IE (Completed) PT (Completed) CZ (Completed) DK (Completed) FR (Completed) BE (Completed) NL (Completed) HU (Completed) DE (Completed) GR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004619-28 | Sponsor Protocol Number: RITS-PO-2019 | Start Date*: 2019-04-24 |
Sponsor Name:Region Örebro län | ||
Full Title: Rituximab - Immunotherapy for Obsessive-Compulsive Disorder. An open pilot study. | ||
Medical condition: Treatment-resistant patients with Obsessive Compulsive Disorder (OCD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004618-17 | Sponsor Protocol Number: RITS-PS-2019 | Start Date*: 2019-04-24 |
Sponsor Name:Region Örebro län | ||
Full Title: Rituximab - Immunotherapy for Schizophrenia spectrum disorder in adults. An open pilot study. | ||
Medical condition: Treatment-resistant patients with schizophrenia spectrum disorder (SSD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004211-30 | Sponsor Protocol Number: 2005-23 | Start Date*: 2005-10-17 |
Sponsor Name:The Norwegian Radium Hospital | ||
Full Title: Penicillin G and an aminoglycoside versus meropenem as initial empiric antibiotic therapy in lymphoma and leukemia patients with febrile neutropenia | ||
Medical condition: Lymphoma and leukemia patients with febrile neutropenia | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006527-13 | Sponsor Protocol Number: CF101-203RA | Start Date*: 2008-06-18 | ||||||||||||||||
Sponsor Name:Can-Fite BioPharma Ltd. | ||||||||||||||||||
Full Title: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study of the Safety and Efficacy of Daily CF101 Administered Orally, When Added to Weekly Methotre... | ||||||||||||||||||
Medical condition: Rheumatoid Arthritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Prohibited by CA) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-006373-25 | Sponsor Protocol Number: A3921029 | Start Date*: 2007-03-23 | |||||||||||
Sponsor Name:Pfizer, S.A. | |||||||||||||
Full Title: ESTUDIO OBSERVACIONAL PROSPECTIVO PARA EVALUAR LA SEGURIDAD A LARGO PLAZO Y EL ESTADO FUNCIONAL DE SUJETOS CON ARTRITIS REUMATOIDE INCLUIDOS PREVIAMENTE EN ESTUDIOS DE CP-690,550 A PROSPECTIVE OBS... | |||||||||||||
Medical condition: CP-690,550 se está desarrollando como fármaco antirreumático modificador de la enfermedad (FARME) para el tratamiento de la artritis reumatoide (AR). CP 690,550 is being developed as a disease mo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) AT (Completed) SE (Completed) SK (Completed) CZ (Completed) GR (Completed) DE (Completed) FI (Completed) BG (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006924-68 | Sponsor Protocol Number: MA22460 | Start Date*: 2010-10-28 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: Extension Phase of the Multi-National Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients with Active Rheumatoid Arthritis on Background Non-biologic DMARD... | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) ES (Completed) NL (Completed) CZ (Completed) PT (Completed) FR (Completed) IT (Completed) GB (Completed) HU (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005648-93 | Sponsor Protocol Number: CD-IA-CAM-3001-1109 | Start Date*: 2012-07-19 | |||||||||||
Sponsor Name:MedImmune Ltd | |||||||||||||
Full Title: An Open-label Extension Study to Evaluate the Long-term Safety of Mavrilimumab in Adult Subjects with Rheumatoid Arthritis | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) HU (Completed) CZ (Completed) DE (Completed) ES (Completed) BG (Completed) GR (Completed) SK (Completed) PT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
